GlassScriptPhysician profile
Reza Dashti
NPI 1801167895
$16,664.19
in general payments reported to CMS, 2019-2025
11 companies · $30.73 in 2025
The $30.73 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $186 · 2021: $567 · 2022: $2,051 · 2023: $35.34 · 2024: $206 · 2025: $30.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| B. Braun Medical Oy | $9,818.62 | 2019 | |
| Penumbra, INC. | $2,159.02 | 2019-2023 | Red 72 |
| Irras USA, INC. | $1,939.46 | 2019-2024 | |
| Silk Road Medical, INC. | $1,718.78 | 2022 | |
| Phenox INC. | $475.69 | 2021-2022 | |
| Stryker Corporation | $173.31 | 2020 | |
| Depuy Synthes Sales INC. | $170.00 | 2019-2024 | Cerepak Uniform, Embotrap |
| Qapel Medical INC | $139.42 | 2024 | |
| Inspiremd LTD | $30.73 | 2025 | Cguard Prime Carotid Stent System |
| Surgalign Spine Technologies, INC. | $26.29 | 2019 | |
| Balt USA, LLC | $12.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reza Dashti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.